ABSTRACT

Pulmonary sarcoidosis is a multisystemic disease of unknown etiology; it affects the lungs and lymphatic nodes, with variable involvement of extrapulmonary disease associated, the diagnosis is based on the findings of a granuloma in lung biopsy, lymphatic nodes, skin, or others organs affected; However, in asymptomatic patients with typical data, the radiographic and clinical diagnostic is enough and the close evolution following is necessary. Systemic corticosteroids is the therapy in use actually but indications are individualized in each case, pulmonary sarcoidosis in stage II and III, the use of systemic steroids do not have doubts specially with persistent or increment in the radiographic infiltrates, presence in the pulmonary function tests of moderate to severe alterations and deterioration, instead inhaled steroids continue been a controversy aspect in medical management in this entity and it’s use is only in mild forms specially when cough or bronchial hyperactivity exist as the unique finding.

KEYWORDS

Pulmonary sarcoidosis, diagnosis, treatment.

REFERENCES

1. Fraser R, Paré P. Enfermedades pulmonares de origen desconocido. En: Sinopsis de enfermedades del tórax. 2ª ed, 1996: 828-844.

2. ATS. Statement on sarcoidosis. Am J Respir Crit Care Med 1999; 160: 736-755.

3. Schwarz M, King T. Sarcoidosis. En: Interstitial lung disease. 2003; 14: 332-386.

4. Selman M. Sarcoidosis. En: Neumopatías intersticiales difusas. 1996; 9: 143-158.

5. Murray J, Nadel J. Textbook of respiratory medicine. In: Infiltrative and interstitial lung diseases. Sarcoidosis. 3º ed, 1717-1732, 2000.

6. Lynch J, Kazerooni E, Gay S. Pulmonary Sarcoidosis. Cl Chest Med 1997; 18(4): 755-785.

7. Baughman R. Can Tuberculosis Cause Sarcoidosis? Chest 1998; 114: 363-364.

8. Wong CF. A case of concomitant tuberculosis and sarcoidosis with mycobacterial DNA present in the sarcoid lesion. Chest 1998: 114: 626- 629.

9. Moller D. Etiology of sarcoidosis. Cl Chest Med 1997; 18(4): 695-706.

10. Judson M, Strange C. Bullous sarcoidosis: a report of three cases. Chest 1998; 114: 1474-1478.

11. Sheffield E. Pathology of sarcoidosis. Cl Chest Med 1997; 18(4): 741-754.

12. Chandra M, Silverman M. Diagnosis of cardiac sarcoidosis aided by MRI. Chest 1996; 110: 562-565.

13. Rizzato G, Fraioli P, Montemurro L. Nephrolithiasis as a presenting feature of chronic sarcoidosis. Thorax 1995; 50: 555-559.

14. Askling J, Grunewald J, et al. Increased risk for cancer following sarcoidosis. Am J Respir Crit Care Med 1999; 160: 1668-1672.

15. Judson M. An approach to the treatment of pulmonary sarcoidosis with corticosteroids: The six phases of treatment. Chest 1999; 115(4): 1158-1165.

16. Reich J, Brouns M, et al. Mediastinoscopy in patients with presumptive stage I sarcoidosis. Chest 1998; 113: 147-153.

17. Nagai S, Izumi T. Broncheoalveolar lavage. Cl Chest Med 1997; 18(4): 787-797.

18. Costabel U, Teschler H. Biochemical changes in sarcoidosis. Cl Chest Med 1997; 18(4): 843-851.

19. Lavergne F, Clerici C, et al. Airway obstruction in bronchial sarcoidosis. Chest 1999; 116: 1194-1199.

20. Medinger A, Khouri S. Sarcoidosis: The value of exercise testing. Chest 2001; 120(1): 93-101.

21. Winterbauer R, Kirtland S, Corley D. Treatment with corticosteroids. Cl Chest Med 1997; 18(4): 843-851.

22. Gibson G. Sarcoidosis: Old and new treatments. Thorax 2001; 56(5): 336-339.

23. Agostini C. Top ten list in sarcoidosis. Chest 2001; 119(6): 1930-1932.

24. Baughman R, Lower E. A clinical approach to the use of methotrexate for sarcoidosis. Thorax 1999; 54: 742-746.

25. Baughman R, Lower E. Steroid sparing alternative treatments for sarcoidosis. Cl Chest Med 1997; 18(4): 853-861.

26. Baltzan M, Mehta S, et al. Randomized trial of prolonged chloroquine therapy in advanced pulmonary sarcoidosis. Am J Respir Crit Care Med 1999; 160: 192-197.

27. Miler A. Of time and experience: Sarcoidosis revisted. Chest 2002; 121(1): 3-5.

28. Arcosoy S. Characteristics and outcomes of patients with sarcoidosis listed for lung transplantation. Chest 2001; 120(3): 873-880.